PMID: 9165093Apr 25, 1997Paper

Primary structure of the propeptide and factor VIII-binding domain of bovine von Willebrand factor

Biochimica Et Biophysica Acta
N JanelD Meyer

Abstract

A 2811 base-pair cDNA, encoding the amino-terminal part of the bovine pre-pro-von Willebrand factor, was characterized and sequenced. The deduced amino acid sequence shares significant homology with the human von Willebrand antigen II and the amino-terminal part of the factor VIII-binding domain of von Willebrand factor. In contrast to human, there is no RGD motif in the bovine von Willebrand antigen II. High levels of Cys, characteristic of D domains, are also found in bovine and the Cys position is markedly conserved between the two species.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Oct 20, 1992·Biochimica Et Biophysica Acta·M R BakhshiE P Kirby
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T N Mayadas, D D Wagner
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R J WiseR J Kaufman
Jan 1, 1990·Annual Review of Cell Biology·D D Wagner
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W R Pearson, D J Lipman
Sep 11, 1986·Nucleic Acids Research·D BonthronS H Orkin
Jun 3, 1986·Biochemistry·K TitaniK Fujikawa
Jun 11, 1986·Nucleic Acids Research·G von Heijne
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R M ScarboroughD A Schooley
Aug 16, 1993·Biochemical and Biophysical Research Communications·J M LavergneD Meyer
Sep 1, 1986·Physical Review C: Nuclear Physics·P Kálmán, J Bergou
Oct 6, 2004·British Journal of Haematology·L HilbertUNKNOWN INSERM Network on Molecular Abnormalities in von Willebrand Disease

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.